# Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers

> **NCT04497519** · PHASE1 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 12 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** inhaled hydroxychloroquine

## Key facts

- **NCT ID:** NCT04497519
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2020-10-15
- **Final completion:** 2020-11-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04497519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04497519, "Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04497519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*